Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01429103 · ClinicalTrials.gov registry record
Hormones and Cognition in the Menopausal Transition
A clinical trial of Age-associated Memory Impairment and Alteration of Cognitive Function, sponsored by University of Rochester.
- Completed
- Registry status
- 117
- Enrollment target
- 1
- Study location
NCT01429103 is a study of Age-associated Memory Impairment and Alteration of Cognitive Function that has completed, run by University of Rochester. The registered enrollment target is 117 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01429103, a study of Age-associated Memory Impairment and Alteration of Cognitive Function, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if the menopausal transition is associated with subjective and objective cognitive declines that ameliorate in menopause. The investigators hypothesize that perimenopause is associated with both subjective memory complaints and objective declines in attentionally mediated cognitive tasks. The investigators also hypothesize that this is time-limited. The investigators predict that as women transition from early perimenopause to late perimenopause their performance on attentionally mediated and verbal memory tasks will decline, and that as they transition from late perimenopause to menopause, their performance will improve.
Conditions Studied
Study Locations (1)
New York
- University of Rochester Clinical Research Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2011-05 |
| Est. Completion | 2016-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01429103
The ClinicalTrials.gov registry entry for NCT01429103 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Age-associated Memory Impairment appearing as the primary indexed condition, and to 0 interventions.
NCT01429103 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01429103 about?
NCT01429103 is a clinical study titled "Hormones and Cognition in the Menopausal Transition". The purpose of this study is to determine if the menopausal transition is associated with subjective and objective cognitive declines that ameliorate in menopause. The investigators hypothesize that perimenopause is associated with both subjective memory complaints and objective declines in attentio...
What is the current status of trial NCT01429103?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2011-05. Estimated completion is 2016-11.
What conditions does trial NCT01429103 study?
This clinical trial studies the following conditions: Age-associated Memory Impairment, Alteration of Cognitive Function.
Who is sponsoring clinical trial NCT01429103?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01429103 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Age-associated Memory Impairment
All registered trials for this condition
Alteration of Cognitive Function
All registered trials for this condition
New York
All trials with a study site in New York
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.